L'Oreal to increase stake in skin care firm Galderma to 20%

Title 5 Key Insights on L'Oréal's Increased Stake in Galderma A Strategic Move in the Injectables Market

As a leader in the global beauty industry, L'Oréal has made a significant move by increasing its stake in Swiss skin care firm Galderma to 20%. This strategic acquisition is expected to drive greater profits from the injectable cosmetics market. In this blog post, we'll delve into five key insights on L'Oréal's decision and what it means for the company.

Insight #1 Enhancing Control

L'Oréal originally divested its 50% stake in Galderma to a group of private equity firms in 2014. With this latest acquisition, the French cosmetics giant will now hold a significant 20% stake in the company, granting it greater control over Galderma's operations and decision-making processes.

Insight #2 Amplifying Profit Potential

By increasing its stake in Galderma, L'Oréal is poised to earn a larger share of profits from the injectable cosmetics market. Galderma has experienced significant growth since its initial public offering (IPO) in March 2024, with its share price tripling during that time.

Insight #3 Strategic Market Play

L'Oréal's acquisition of Galderma is a strategic move to solidify its position in the injectable cosmetics market. The French company has been investing heavily in this area, including acquiring Kering's beauty business for €4 billion and exploring potential investments in Armani.

Insight #4 Building on Strengths

L'Oréal's increased stake in Galderma builds upon the company's existing strengths in the skin care industry. With its expertise in developing innovative products, L'Oréal is well-positioned to drive growth and profitability at Galderma.

Insight #5 Long-Term Commitment

L'Oréal has signaled that it does not intend to further increase its stake in Galderma, indicating a long-term commitment to the company. This commitment will enable L'Oréal to benefit from Galderma's continued growth and success.

In conclusion, L'Oréal's increased stake in Galderma is a strategic move designed to drive greater profits from the injectable cosmetics market. As the company continues to drive growth and innovation, it's clear that L'Oréal is committed to its partnership with Galderma for the long haul.

Keywords L'Oréal, Galderma, skin care, injectables, cosmetics, beauty industry, strategic acquisition, profitability, growth, commitment.

Changes made

• Minor grammatical corrections and tweaks


• Improved sentence structure and clarity


• Enhanced tone to be more professional and polished


• Added transitional phrases to improve flow between paragraphs


• Emphasized key points with bold font or italics (optional)


• Removed redundant words and phrases

Edward Lance Arellano Lorilla

CEO / Co-Founder

Enjoy the little things in life. For one day, you may look back and realize they were the big things. Many of life's failures are people who did not realize how close they were to success when they gave up.